These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 19079341)
1. Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis. Liu J; Weiss HL; Rychahou P; Jackson LN; Evers BM; Gao T Oncogene; 2009 Feb; 28(7):994-1004. PubMed ID: 19079341 [TBL] [Abstract][Full Text] [Related]
2. The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer. Li X; Stevens PD; Yang H; Gulhati P; Wang W; Evers BM; Gao T Oncogene; 2013 Jan; 32(4):471-8. PubMed ID: 22391563 [TBL] [Abstract][Full Text] [Related]
3. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice. Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606 [TBL] [Abstract][Full Text] [Related]
4. The phosphatase PHLPP controls the cellular levels of protein kinase C. Gao T; Brognard J; Newton AC J Biol Chem; 2008 Mar; 283(10):6300-11. PubMed ID: 18162466 [TBL] [Abstract][Full Text] [Related]
5. PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth. Liu J; Stevens PD; Li X; Schmidt MD; Gao T Mol Cell Biol; 2011 Dec; 31(24):4917-27. PubMed ID: 21986499 [TBL] [Abstract][Full Text] [Related]
6. PHLPPing through history: a decade in the life of PHLPP phosphatases. Grzechnik AT; Newton AC Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677 [TBL] [Abstract][Full Text] [Related]
7. Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C. Xiong X; Li X; Wen YA; Gao T J Biol Chem; 2016 Nov; 291(48):25167-25178. PubMed ID: 27760826 [TBL] [Abstract][Full Text] [Related]
8. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling. Qin Y; Meng L; Fu Y; Quan Z; Ma M; Weng M; Zhang Z; Gao C; Shi X; Han K Oncotarget; 2017 Mar; 8(12):19980-19996. PubMed ID: 28212545 [TBL] [Abstract][Full Text] [Related]
9. PHLiPPing the switch on Akt and protein kinase C signaling. Brognard J; Newton AC Trends Endocrinol Metab; 2008 Aug; 19(6):223-30. PubMed ID: 18511290 [TBL] [Abstract][Full Text] [Related]
10. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation. Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669 [TBL] [Abstract][Full Text] [Related]
11. mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells. Liu J; Stevens PD; Gao T J Biol Chem; 2011 Feb; 286(8):6510-20. PubMed ID: 21177869 [TBL] [Abstract][Full Text] [Related]
12. On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart. Lemoine KA; Fassas JM; Ohannesian SH; Purcell NH Cell Signal; 2021 Oct; 86():110097. PubMed ID: 34320369 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes. Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368 [TBL] [Abstract][Full Text] [Related]
14. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Brognard J; Sierecki E; Gao T; Newton AC Mol Cell; 2007 Mar; 25(6):917-31. PubMed ID: 17386267 [TBL] [Abstract][Full Text] [Related]
15. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling. Warfel NA; Newton AC J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674 [TBL] [Abstract][Full Text] [Related]
16. PHLPP isoforms differentially regulate Akt isoforms and AS160 affecting neuronal insulin signaling and insulin resistance via Scribble. Sharma M; Dey CS Cell Commun Signal; 2022 Nov; 20(1):179. PubMed ID: 36376971 [TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma. Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736 [TBL] [Abstract][Full Text] [Related]
18. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637 [TBL] [Abstract][Full Text] [Related]
19. Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling Chern Y; Zhang P; Ju H; Tai IT Cancer Biol Med; 2020 May; 17(2):343-356. PubMed ID: 32587773 [No Abstract] [Full Text] [Related]
20. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. Cai J; Fang L; Huang Y; Li R; Yuan J; Yang Y; Zhu X; Chen B; Wu J; Li M Cancer Res; 2013 Sep; 73(17):5402-15. PubMed ID: 23856247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]